ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 23.60
-1.05 (-4.26%)
Feb 2, 2026, 1:35 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 19.49 billion as of January 30, 2026. Its market cap has increased by 11.04% in one year.
Market Cap
19.49B
Enterprise Value
17.42B
Revenue
3.19B
Ranking
n/a
PE Ratio
102.63
Stock Price
23.60
Market Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 19.49B, a decrease of -35.96%. That is a compound annual growth rate of -2.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 19.49B | 47.16% |
| Dec 31, 2025 | 13.24B | -24.04% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 30.09B |
| TTY Biopharm Company | 21.21B |
| Alar Pharmaceuticals | 18.00B |
| Grape King Bio | 17.92B |
| Synmosa Biopharma | 16.25B |
| YungShin Global Holding | 14.84B |
| Foresee Pharmaceuticals | 13.04B |
| Handa Pharmaceuticals | 13.00B |